Senator Kyrsten Sinema, a Democrat from Arizona, speaks during a Senate Commerce, Science and Transportation Subcommittee hearing in Washington, D.C., U.S., on Wednesday, March 4, 2020. Republicans and Democrats agreed on a $7.8 billion emergency spending bill to fund the U.S. governments response to the coronavirus outbreak, according to Senate Appropriations Chairman Richard Shelby. Photographer: Stefani Reynolds/Bloomberg via Getty Images

Sen. Kyrsten Sinema formed a congressional caucus to raise “awareness of the benefits of personalized medicine” in February. Soon after that, employees of pharmaceutical companies donated $35,000 to her campaign committee.

Amgen gave $5,000. So did Genentech and Merck. Sanofi, Pfizer and Eli Lilly all gave $2,500. Each of those companies has invested heavily in personalized medicine, which promises individually tailored drugs that can cost a patient hundreds of thousands of dollars.

The article was published at A Senator From Arizona Emerges As A Pharma Favorite.


Please enter your comment!
Please enter your name here